Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Alpha Tau Medical Ltd. before investing.

In this article, we go over a few key elements for understanding Alpha Tau Medical Ltd.’s stock price such as:

• Alpha Tau Medical Ltd.’s current stock price and volume
• Why Alpha Tau Medical Ltd.’s stock price changed recently
• Upgrades and downgrades for DRTS from analysts
• DRTS’s stock price momentum as measured by its relative strength

About Alpha Tau Medical Ltd. (DRTS)

Before we jump into Alpha Tau Medical Ltd.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

Want to learn more about Alpha Tau Medical Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Alpha Tau Medical Ltd..

Alpha Tau Medical Ltd.’s Stock Price as of Market Close

As of December 05, 2025, 4:00 PM, CST, Alpha Tau Medical Ltd.’s stock price was $3.890.

Alpha Tau Medical Ltd. is down 4.19% from its previous closing price of $4.060.

During the last market session, Alpha Tau Medical Ltd.’s stock traded between $3.870 and $4.160. Currently, there are approximately 80.45 million shares outstanding for Alpha Tau Medical Ltd..

Alpha Tau Medical Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Alpha Tau Medical Ltd. Stock Price History

Alpha Tau Medical Ltd.’s (DRTS) price is currently down 2.02% so far this month.

During the month of December, Alpha Tau Medical Ltd.’s stock price has reached a high of $4.280 and a low of $3.670.

Over the last year, Alpha Tau Medical Ltd. has hit prices as high as $4.690 and as low as $2.300. Year to date, Alpha Tau Medical Ltd.’s stock is up 25.48%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Alpha Tau Medical Ltd. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 05, 2025, there was 1 analyst who downgraded Alpha Tau Medical Ltd.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Alpha Tau Medical Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Alpha Tau Medical Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Alpha Tau Medical Ltd. (DRTS) by visiting AAII Stock Evaluator.

Relative Price Strength of Alpha Tau Medical Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 05, 2025, Alpha Tau Medical Ltd. has a weighted four-quarter relative price strength of 2.08%, which translates to a Momentum Score of 65 and is considered to be Strong.

Want to learn more about how Alpha Tau Medical Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Alpha Tau Medical Ltd. Stock Price: Bottom Line

As of December 5, 2025, Alpha Tau Medical Ltd.’s stock price is $3.890, which is down 4.19% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Alpha Tau Medical Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.